In the last 12 months, insiders at Intellia Therapeutics, Inc. ($NTLA) filed 196 transactions with the SEC: 2 open-market purchases totaling $2,405,500 and 63 sales totaling $5,550,715. Net insider sentiment: net selling.
Intellia Therapeutics, Inc. operates in the In vitro & in vivo diagnostic substances industry (Life sciences sector).
Most Active Insiders
- LEONARD JOHN M (President and CEO) — 25 transactions totaling $2,691,655
- Cohen Fred E (Not found) — 5 transactions totaling $1,402,500
- CHASE WILLIAM J (Not found) — 5 transactions totaling $1,003,000
- Clark Eliana (EVP, Chief Technical Officer) — 26 transactions totaling $751,717
- Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) — 17 transactions totaling $520,842
View all SEC Filings for Intellia Therapeutics, Inc. (NTLA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 1, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 87543 | $0.00 | 87,543.0000 | 115,829,926 | 9999.99% | 0.08% |
| March 1, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | A | Common Stock | 39200 | $0.00 | 137,733.0000 | 115,829,926 | 39.78% | 0.03% |
| March 1, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | A | Stock Option (right to buy) | 56000 | $0.00 | 56,000.0000 | 115,829,926 | 9999.99% | 0.05% |
| March 1, 2026 | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 7353 | $0.00 | 94,471.0000 | 115,829,926 | 8.44% | 0.01% |
| March 2, 2026 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 607 | $13.78 | 93,864.0000 | 115,829,926 | 0.64% | 0.00% |
| March 1, 2026 | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 10505 | $0.00 | 10,505.0000 | 115,829,926 | 9999.99% | 0.01% |
| March 1, 2026 | Dube Michael P | VP, Chief Accounting Officer | A | Common Stock | 17250 | $0.00 | 69,527.0000 | 115,829,926 | 33.00% | 0.01% |
| March 1, 2026 | LEONARD JOHN M | President and CEO | A | Common Stock | 156400 | $0.00 | 1,228,154.0000 | 115,829,926 | 14.59% | 0.14% |
| March 1, 2026 | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 225400 | $0.00 | 225,400.0000 | 115,829,926 | 9999.99% | 0.19% |
| March 1, 2026 | BASTA JAMES | EVP, General Counsel | A | Common Stock | 46080 | $0.00 | 158,005.0000 | 115,829,926 | 41.17% | 0.04% |
| March 2, 2026 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 1211 | $13.78 | 156,794.0000 | 115,829,926 | 0.77% | 0.00% |
| March 1, 2026 | BASTA JAMES | EVP, General Counsel | A | Stock Option (right to buy) | 65829 | $0.00 | 65,829.0000 | 115,829,926 | 9999.99% | 0.06% |
| March 1, 2026 | Lebwohl David | EVP, Chief Medical Officer | A | Common Stock | 9943 | $0.00 | 131,192.0000 | 115,829,926 | 8.20% | 0.01% |
| March 1, 2026 | Lebwohl David | EVP, Chief Medical Officer | A | Stock Option (right to buy) | 14204 | $0.00 | 14,204.0000 | 115,829,926 | 9999.99% | 0.01% |
| March 1, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | A | Common Stock | 61280 | $0.00 | 160,963.0000 | 115,829,926 | 61.47% | 0.05% |
| Jan. 5, 2026 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 10397 | $9.21 | 101,528.0000 | 115,829,926 | 9.29% | 0.01% |
| Jan. 5, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | S | Common Stock | 8508 | $9.21 | 98,533.0000 | 115,829,926 | 7.95% | 0.01% |
| Jan. 5, 2026 | LEONARD JOHN M | President and CEO | S | Common Stock | 34146 | $9.21 | 1,071,754.0000 | 115,829,926 | 3.09% | 0.03% |
| Jan. 5, 2026 | Cohen Fred E | Not found | P | Common Stock | 150000 | $9.35 | 207,453.0000 | 115,829,926 | 261.08% | 0.13% |
| Jan. 5, 2026 | Lebwohl David | EVP, Chief Medical Officer | S | Common Stock | 11903 | $9.21 | 121,249.0000 | 115,829,926 | 8.94% | 0.01% |
| Jan. 5, 2026 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 9515 | $9.21 | 87,118.0000 | 115,829,926 | 9.85% | 0.01% |
| Jan. 5, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | S | Common Stock | 6379 | $9.21 | 99,683.0000 | 115,829,926 | 6.01% | 0.01% |
| Jan. 5, 2026 | Dube Michael P | VP, Chief Accounting Officer | S | Common Stock | 2989 | $9.21 | 52,277.0000 | 115,829,926 | 5.41% | 0.00% |
| Dec. 11, 2025 | LEONARD JOHN M | President and CEO | M | Stock Option (right to buy) | 49959 | $0.00 | 8,557.0000 | 115,829,926 | 85.38% | 0.04% |
| Dec. 12, 2025 | LEONARD JOHN M | President and CEO | M | Stock Option (right to buy) | 8557 | $0.00 | 0.0000 | 115,829,926 | 100.00% | 0.01% |
| Dec. 12, 2025 | LEONARD JOHN M | President and CEO | M | Common Stock | 8557 | $6.83 | 1,105,900.0000 | 115,829,926 | 0.78% | 0.01% |
| Dec. 11, 2025 | LEONARD JOHN M | President and CEO | S | Common Stock | 5355 | $9.59 | 1,097,343.0000 | 115,829,926 | 0.49% | 0.00% |
| Dec. 11, 2025 | LEONARD JOHN M | President and CEO | S | Common Stock | 32832 | $9.47 | 1,102,698.0000 | 115,829,926 | 2.89% | 0.03% |
| Dec. 11, 2025 | LEONARD JOHN M | President and CEO | S | Common Stock | 49959 | $9.49 | 1,135,530.0000 | 115,829,926 | 4.21% | 0.04% |
| Dec. 11, 2025 | LEONARD JOHN M | President and CEO | M | Common Stock | 49959 | $6.83 | 1,185,489.0000 | 115,829,926 | 4.40% | 0.04% |
| Oct. 1, 2025 | Dube Michael P | VP, Chief Accounting Officer | S | Common Stock | 1871 | $17.38 | 55,266.0000 | 103,517,460 | 3.27% | 0.00% |
| Oct. 1, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | S | Common Stock | 31 | $17.38 | 105,184.0000 | 103,517,460 | 0.03% | 0.00% |
| Aug. 20, 2025 | CHASE WILLIAM J | Not found | P | Common Stock | 100000 | $10.03 | 134,693.0000 | 103,517,460 | 288.24% | 0.10% |
| July 23, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | S | Common Stock | 7462 | $14.02 | 106,062.0000 | 103,517,460 | 6.57% | 0.01% |
| July 1, 2025 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 1022 | $9.82 | 95,369.0000 | 103,517,460 | 1.06% | 0.00% |
| July 2, 2025 | Dube Michael P | VP, Chief Accounting Officer | S | Common Stock | 2503 | $9.95 | 57,137.0000 | 103,517,460 | 4.20% | 0.00% |
| July 1, 2025 | GOODMAN JESSE | Not found | S | Common Stock | 1547 | $9.23 | 24,359.0000 | 103,517,460 | 5.97% | 0.00% |
| June 30, 2025 | GOODMAN JESSE | Not found | S | Common Stock | 1547 | $9.56 | 25,906.0000 | 103,517,460 | 5.64% | 0.00% |
| June 11, 2025 | Keresty Georgia | Not found | A | Common Stock | 8000 | $0.00 | 31,883.0000 | 103,517,460 | 33.50% | 0.01% |
| June 11, 2025 | Keresty Georgia | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 11, 2025 | GOODMAN JESSE | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 11, 2025 | Goff Brian | Not found | A | Common Stock | 8000 | $0.00 | 23,409.0000 | 103,517,460 | 51.92% | 0.01% |
| June 11, 2025 | GOODMAN JESSE | Not found | A | Common Stock | 8000 | $0.00 | 27,453.0000 | 103,517,460 | 41.12% | 0.01% |
| June 11, 2025 | Bhanji Muna | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 11, 2025 | Cohen Fred E | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 11, 2025 | Cohen Fred E | Not found | A | Common Stock | 8000 | $0.00 | 57,453.0000 | 103,517,460 | 16.18% | 0.01% |
| June 11, 2025 | CHASE WILLIAM J | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 11, 2025 | CHASE WILLIAM J | Not found | A | Common Stock | 8000 | $0.00 | 34,693.0000 | 103,517,460 | 29.97% | 0.01% |
| June 11, 2025 | Bhanji Muna | Not found | A | Common Stock | 8000 | $0.00 | 27,203.0000 | 103,517,460 | 41.66% | 0.01% |
| June 11, 2025 | Goff Brian | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 11, 2025 | Verwiel Frank | Not found | A | Common Stock | 8000 | $0.00 | 25,948.0000 | 103,517,460 | 44.57% | 0.01% |
| June 11, 2025 | Verwiel Frank | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| April 29, 2025 | Bhanji Muna | Not found | S | Common Stock | 265 | $8.50 | 19,203.0000 | 103,517,460 | 1.36% | 0.00% |
| March 1, 2025 | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 196000 | $0.00 | 196,000.0000 | 103,517,460 | 9999.99% | 0.19% |
| March 1, 2025 | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 32000 | $0.00 | 96,048.0000 | 103,517,460 | 49.96% | 0.03% |
| March 4, 2025 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 679 | $8.99 | 95,369.0000 | 103,517,460 | 0.71% | 0.00% |
| March 1, 2025 | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 45714 | $0.00 | 45,714.0000 | 103,517,460 | 9999.99% | 0.04% |
| March 1, 2025 | LEONARD JOHN M | President and CEO | A | Common Stock | 136000 | $0.00 | 1,135,530.0000 | 103,517,460 | 13.61% | 0.13% |
| March 1, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | A | Common Stock | 47200 | $0.00 | 113,524.0000 | 103,517,460 | 71.17% | 0.05% |
| March 1, 2025 | Dulac Edward J III | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 67429 | $0.00 | 67,429.0000 | 103,517,460 | 9999.99% | 0.07% |
| March 1, 2025 | Dube Michael P | VP, Chief Accounting Officer | A | Common Stock | 14000 | $0.00 | 59,640.0000 | 103,517,460 | 30.67% | 0.01% |
| March 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | A | Common Stock | 43200 | $0.00 | 130,866.0000 | 103,517,460 | 49.28% | 0.04% |
| March 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | A | Stock Option (right to buy) | 61714 | $0.00 | 61,714.0000 | 103,517,460 | 9999.99% | 0.06% |
| March 1, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | A | Common Stock | 37600 | $0.00 | 105,215.0000 | 103,517,460 | 55.61% | 0.04% |
| March 1, 2025 | Schultes Birgit C | EVP, Chief Scientific Officer | A | Stock Option (right to buy) | 53714 | $0.00 | 53,714.0000 | 103,517,460 | 9999.99% | 0.05% |
| March 1, 2025 | BASTA JAMES | EVP, General Counsel | A | Common Stock | 40000 | $0.00 | 114,497.0000 | 103,517,460 | 53.69% | 0.04% |
| March 4, 2025 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 2572 | $8.99 | 111,925.0000 | 103,517,460 | 2.25% | 0.00% |
| March 1, 2025 | BASTA JAMES | EVP, General Counsel | A | Stock Option (right to buy) | 57143 | $0.00 | 57,143.0000 | 103,517,460 | 9999.99% | 0.06% |
| Jan. 29, 2025 | Bhanji Muna | Not found | S | Common Stock | 265 | $9.97 | 19,468.0000 | 0 | 1.34% | 0.00% |
| Jan. 3, 2025 | Dube Michael P | VP, Chief Accounting Officer | S | Common Stock | 1372 | $12.18 | 45,640.0000 | 0 | 2.92% | 0.00% |
| Jan. 3, 2025 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S | Common Stock | 8966 | $12.18 | 77,388.0000 | 0 | 10.38% | 0.00% |
| Jan. 3, 2025 | LEONARD JOHN M | President and CEO | S | Common Stock | 26807 | $12.18 | 999,530.0000 | 0 | 2.61% | 0.00% |
| Jan. 3, 2025 | Hicks Derek | EVP, Chief Business Officer | S | Common Stock | 6502 | $12.18 | 59,878.0000 | 0 | 9.80% | 0.00% |
| Jan. 3, 2025 | Lebwohl David | EVP, Chief Medical Officer | S | Common Stock | 9557 | $12.18 | 87,666.0000 | 0 | 9.83% | 0.00% |
| Jan. 3, 2025 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 7074 | $12.18 | 74,497.0000 | 0 | 8.67% | 0.00% |
| Jan. 2, 2025 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 556 | $12.03 | 71,470.0000 | 0 | 0.77% | 0.00% |
| Jan. 3, 2025 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 7422 | $12.18 | 64,048.0000 | 0 | 10.38% | 0.00% |
| Jan. 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | M | Restricted Stock Unit | 3189 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2025 | Lebwohl David | EVP, Chief Medical Officer | M | Common Stock | 3189 | $0.00 | 97,223.0000 | 0 | 3.39% | 0.00% |
| Jan. 1, 2025 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | M | Restricted Stock Unit | 3500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2025 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | M | Common Stock | 3500 | $0.00 | 86,354.0000 | 0 | 4.22% | 0.00% |
| Jan. 1, 2025 | LEONARD JOHN M | President and CEO | M | Restricted Stock Unit | 7850 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2025 | LEONARD JOHN M | President and CEO | M | Common Stock | 7850 | $0.00 | 1,026,337.0000 | 0 | 0.77% | 0.00% |
| Oct. 2, 2024 | Dube Michael P | VP, Chief Accounting Officer | S | Common Stock | 2012 | $19.01 | 47,012.0000 | 0 | 4.10% | 0.00% |
| July 22, 2024 | Dulac Edward J III | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 96219 | $0.00 | 96,219.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2024 | Dulac Edward J III | EVP, Chief Financial Officer | A | Common Stock | 66324 | $0.00 | 66,324.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2024 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 405 | $22.93 | 71,470.0000 | 0 | 0.56% | 0.00% |
| July 1, 2024 | Dube Michael P | VP, PAO and Interim PFO | A | Common Stock | 17801 | $0.00 | 49,024.0000 | 0 | 57.01% | 0.00% |
| June 17, 2024 | Verwiel Frank | Not found | S | Common Stock | 1505 | $25.00 | 17,948.0000 | 0 | 7.74% | 0.00% |
| June 13, 2024 | Goff Brian | Not found | A | Stock Option (right to buy) | 22297 | $0.00 | 22,297.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Goff Brian | Not found | A | Common Stock | 15409 | $0.00 | 15,409.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Keresty Georgia | Not found | A | Common Stock | 7737 | $0.00 | 23,883.0000 | 0 | 47.92% | 0.00% |
| June 12, 2024 | Verwiel Frank | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Verwiel Frank | Not found | A | Common Stock | 7737 | $0.00 | 19,453.0000 | 0 | 66.04% | 0.00% |
| June 12, 2024 | Cohen Fred E | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Bhanji Muna | Not found | A | Common Stock | 7737 | $0.00 | 19,733.0000 | 0 | 64.50% | 0.00% |
| June 12, 2024 | Bhanji Muna | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | CHASE WILLIAM J | Not found | A | Common Stock | 7737 | $0.00 | 26,693.0000 | 0 | 40.82% | 0.00% |
| June 12, 2024 | CHASE WILLIAM J | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Cohen Fred E | Not found | A | Common Stock | 7737 | $0.00 | 49,453.0000 | 0 | 18.55% | 0.00% |
| June 12, 2024 | GOODMAN JESSE | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | GOODMAN JESSE | Not found | A | Common Stock | 7737 | $0.00 | 19,453.0000 | 0 | 66.04% | 0.00% |
| June 12, 2024 | Keresty Georgia | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Goddard Glenn | EVP, Chief Financial Officer | A | Common Stock | 28628 | $0.00 | 69,213.0000 | 0 | 70.54% | 0.00% |
| March 1, 2024 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | A | Common Stock | 37966 | $0.00 | 81,893.0000 | 0 | 86.43% | 0.00% |
| March 1, 2024 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | A | Stock Option (right to buy) | 54794 | $0.00 | 54,794.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | BASTA JAMES | EVP, General Counsel | A | Common Stock | 32394 | $0.00 | 83,868.0000 | 0 | 62.93% | 0.00% |
| March 4, 2024 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 2297 | $32.99 | 81,571.0000 | 0 | 2.74% | 0.00% |
| March 1, 2024 | BASTA JAMES | EVP, General Counsel | A | Stock Option (right to buy) | 46752 | $0.00 | 46,752.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Hicks Derek | EVP, Chief Business Officer | A | Common Stock | 29393 | $0.00 | 66,380.0000 | 0 | 79.47% | 0.00% |
| March 1, 2024 | Hicks Derek | EVP, Chief Business Officer | A | Stock Option (right to buy) | 42421 | $0.00 | 42,421.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 31230 | $0.00 | 72,075.0000 | 0 | 76.46% | 0.00% |
| March 4, 2024 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 605 | $32.99 | 71,470.0000 | 0 | 0.84% | 0.00% |
| March 1, 2024 | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 45072 | $0.00 | 45,072.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | LEONARD JOHN M | President and CEO | A | Common Stock | 113586 | $0.00 | 1,018,487.0000 | 0 | 12.55% | 0.00% |
| March 1, 2024 | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 163929 | $0.00 | 163,929.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Lebwohl David | EVP, Chief Medical Officer | A | Common Stock | 38701 | $0.00 | 93,073.0000 | 0 | 71.18% | 0.00% |
| March 1, 2024 | Lebwohl David | EVP, Chief Medical Officer | A | Stock Option (right to buy) | 55855 | $0.00 | 55,855.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Goddard Glenn | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 41316 | $0.00 | 41,316.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2024 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S | Common Stock | 667 | $29.38 | 43,927.0000 | 0 | 1.50% | 0.00% |
| Jan. 8, 2024 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S | Common Stock | 1608 | $28.66 | 44,594.0000 | 0 | 3.48% | 0.00% |
| Jan. 3, 2024 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 4301 | $29.46 | 40,845.0000 | 0 | 9.53% | 0.00% |
| Jan. 3, 2024 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 307 | $30.12 | 45,146.0000 | 0 | 0.68% | 0.00% |
| Jan. 3, 2024 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 3805 | $29.46 | 51,474.0000 | 0 | 6.88% | 0.00% |
| Jan. 3, 2024 | Hicks Derek | EVP, Chief Business Officer | S | Common Stock | 3877 | $29.46 | 36,987.0000 | 0 | 9.49% | 0.00% |
| Jan. 3, 2024 | Goddard Glenn | EVP, Chief Financial Officer | S | Common Stock | 5365 | $29.46 | 40,585.0000 | 0 | 11.68% | 0.00% |
| Jan. 3, 2024 | Lebwohl David | EVP, Chief Medical Officer | S | Common Stock | 5843 | $29.46 | 54,372.0000 | 0 | 9.70% | 0.00% |
| Jan. 3, 2024 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S | Common Stock | 5532 | $29.46 | 46,202.0000 | 0 | 10.69% | 0.00% |
| Jan. 3, 2024 | LEONARD JOHN M | President and CEO | S | Common Stock | 19223 | $29.46 | 904,901.0000 | 0 | 2.08% | 0.00% |
| Jan. 1, 2024 | Lebwohl David | EVP, Chief Medical Officer | M | Restricted Stock Unit | 3187 | $0.00 | 3,189.0000 | 0 | 49.98% | 0.00% |
| Jan. 1, 2024 | LEONARD JOHN M | President and CEO | M | Restricted Stock Unit | 7848 | $0.00 | 7,850.0000 | 0 | 49.99% | 0.00% |
| Jan. 1, 2024 | Goddard Glenn | EVP, Chief Financial Officer | M | Common Stock | 3062 | $0.00 | 45,950.0000 | 0 | 7.14% | 0.00% |
| Jan. 1, 2024 | Goddard Glenn | EVP, Chief Financial Officer | M | Restricted Stock Unit | 3062 | $0.00 | 3,064.0000 | 0 | 49.98% | 0.00% |
| Jan. 1, 2024 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | M | Common Stock | 3500 | $0.00 | 51,734.0000 | 0 | 7.26% | 0.00% |
| Jan. 1, 2024 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | M | Restricted Stock Unit | 3500 | $0.00 | 3,500.0000 | 0 | 50.00% | 0.00% |
| Jan. 1, 2024 | Lebwohl David | EVP, Chief Medical Officer | M | Common Stock | 3187 | $0.00 | 60,215.0000 | 0 | 5.59% | 0.00% |
| Jan. 1, 2024 | LEONARD JOHN M | President and CEO | M | Common Stock | 7848 | $0.00 | 924,124.0000 | 0 | 0.86% | 0.00% |
| Oct. 31, 2023 | Bhanji Muna | Director | S | Common Stock | 265 | $23.90 | 11,996.0000 | 0 | 2.16% | 0.00% |
| July 31, 2023 | Bhanji Muna | Director | S | Common Stock | 265 | $42.33 | 12,261.0000 | 0 | 2.12% | 0.00% |
| July 6, 2023 | Bhanji Muna | Director | S | Common Stock | 1867 | $39.30 | 12,526.0000 | 0 | 12.97% | 0.00% |
| July 3, 2023 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 360 | $40.51 | 45,146.0000 | 0 | 0.79% | 0.00% |
| June 20, 2023 | Clark Eliana | EVP, Chief Technical Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 57,750.0000 | 0 | 7.97% | 0.00% |
| June 20, 2023 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 5000 | $45.00 | 45,146.0000 | 0 | 9.97% | 0.00% |
| June 20, 2023 | Clark Eliana | EVP, Chief Technical Officer | M | Common Stock | 5000 | $12.27 | 50,146.0000 | 0 | 11.08% | 0.00% |
| June 14, 2023 | Verwiel Frank | Director | A | Common Stock | 4425 | $0.00 | 11,716.0000 | 0 | 60.69% | 0.00% |
| June 14, 2023 | Keresty Georgia | Director | A | Common Stock | 4425 | $0.00 | 16,146.0000 | 0 | 37.75% | 0.00% |
| June 14, 2023 | GOODMAN JESSE | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Crowley John F | Director | A | Common Stock | 4425 | $0.00 | 11,716.0000 | 0 | 60.69% | 0.00% |
| June 14, 2023 | Crowley John F | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Cohen Fred E | Director | A | Common Stock | 4425 | $0.00 | 41,716.0000 | 0 | 11.87% | 0.00% |
| June 14, 2023 | Cohen Fred E | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Bhanji Muna | Director | A | Common Stock | 4425 | $0.00 | 14,393.0000 | 0 | 44.39% | 0.00% |
| June 14, 2023 | Bhanji Muna | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Keresty Georgia | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | GOODMAN JESSE | Director | A | Common Stock | 4425 | $0.00 | 11,716.0000 | 0 | 60.69% | 0.00% |
| June 14, 2023 | CHASE WILLIAM J | Director | A | Common Stock | 1673 | $0.00 | 18,956.0000 | 0 | 9.68% | 0.00% |
| June 14, 2023 | CHASE WILLIAM J | Director | A | Stock Option (right to buy) | 2447 | $0.00 | 2,447.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Verwiel Frank | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| April 14, 2023 | CHASE WILLIAM J | Director | A | Common Stock | 10483 | $0.00 | 17,283.0000 | 0 | 154.16% | 0.00% |
| April 14, 2023 | CHASE WILLIAM J | Director | A | Stock Option (Right to Buy) | 14931 | $0.00 | 14,931.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Goddard Glenn | EVP, Chief Financial Officer | A | Common Stock | 27484 | $0.00 | 42,888.0000 | 0 | 178.42% | 0.00% |
| March 1, 2023 | Lebwohl David | EVP, Chief Medical Officer | A | Stock Option (right to buy) | 43342 | $0.00 | 43,342.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | BASTA JAMES | EVP, General Counsel | A | Stock Option (right to buy) | 34674 | $0.00 | 34,674.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 1088 | $43.88 | 55,279.0000 | 0 | 1.93% | 0.00% |
| March 1, 2023 | BASTA JAMES | EVP, General Counsel | A | Common Stock | 12269 | $0.00 | 56,367.0000 | 0 | 27.82% | 0.00% |
| March 1, 2023 | BASTA JAMES | EVP, General Counsel | A | Common Stock | 24539 | $0.00 | 44,098.0000 | 0 | 125.46% | 0.00% |
| March 1, 2023 | Clark Eliana | EVP, Chief Technical Officer | A | Stock Option (right to buy) | 34674 | $0.00 | 34,674.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 6134 | $0.00 | 45,146.0000 | 0 | 15.72% | 0.00% |
| March 1, 2023 | Clark Eliana | EVP, Chief Technical Officer | A | Common Stock | 24539 | $0.00 | 39,012.0000 | 0 | 169.55% | 0.00% |
| March 1, 2023 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | A | Stock Option (right to buy) | 42302 | $0.00 | 42,302.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | A | Common Stock | 29938 | $0.00 | 47,567.0000 | 0 | 169.82% | 0.00% |
| March 1, 2023 | Goddard Glenn | EVP, Chief Financial Officer | A | Stock Option (right to buy) | 38834 | $0.00 | 38,834.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | LEONARD JOHN M | President and CEO | A | Common Stock | 91036 | $0.00 | 916,276.0000 | 0 | 11.03% | 0.00% |
| March 1, 2023 | LEONARD JOHN M | President and CEO | A | Stock Option (right to buy) | 128631 | $0.00 | 128,631.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Lebwohl David | EVP, Chief Medical Officer | A | Common Stock | 30674 | $0.00 | 56,361.0000 | 0 | 119.41% | 0.00% |
| March 1, 2023 | Hicks Derek | EVP, Chief Business Officer | A | Common Stock | 23558 | $0.00 | 40,864.0000 | 0 | 136.13% | 0.00% |
| March 1, 2023 | Hicks Derek | EVP, Chief Business Officer | A | Stock option (right to buy) | 33287 | $0.00 | 33,287.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2023 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S | Common Stock | 2508 | $37.21 | 19,959.0000 | 0 | 11.16% | 0.00% |
| Jan. 4, 2023 | BASTA JAMES | EVP, General Counsel | S | Common Stock | 1138 | $37.21 | 19,559.0000 | 0 | 5.50% | 0.00% |
| Jan. 4, 2023 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 1692 | $37.21 | 14,473.0000 | 0 | 10.47% | 0.00% |
| Jan. 3, 2023 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 231 | $34.48 | 16,165.0000 | 0 | 1.41% | 0.00% |
| July 1, 2022 | Clark Eliana | EVP, Chief Technical Officer | S | Common Stock | 105 | $51.74 | 16,165.0000 | 0 | 0.65% | 0.00% |
| Jan. 4, 2023 | Goddard Glenn | EVP, Chief Financial Officer | S | Common Stock | 2427 | $37.21 | 15,404.0000 | 0 | 13.61% | 0.00% |
| Jan. 4, 2023 | Lebwohl David | EVP, Chief Medical Officer | S | Common Stock | 2574 | $37.21 | 25,687.0000 | 0 | 9.11% | 0.00% |
| Jan. 4, 2023 | Hicks Derek | EVP, Chief Business Officer | S | Common Stock | 1812 | $37.21 | 17,306.0000 | 0 | 9.48% | 0.00% |
| Jan. 4, 2023 | LEONARD JOHN M | President and CEO | S | Common Stock | 6673 | $37.21 | 825,240.0000 | 0 | 0.80% | 0.00% |
| Jan. 5, 2023 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S | Common Stock | 689 | $39.10 | 17,629.0000 | 0 | 3.76% | 0.00% |
| Jan. 5, 2023 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | S | Common Stock | 1641 | $38.22 | 18,318.0000 | 0 | 8.22% | 0.00% |
| Jan. 1, 2023 | LEONARD JOHN M | President and CEO | M | Common Stock | 7848 | $0.00 | 831,913.0000 | 0 | 0.95% | 0.00% |
| Jan. 1, 2023 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | M | Common Stock | 3500 | $0.00 | 22,467.0000 | 0 | 18.45% | 0.00% |
| Jan. 1, 2023 | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | M | Restricted Stock Unit | 3500 | $0.00 | 7,000.0000 | 0 | 33.33% | 0.00% |
| Jan. 1, 2023 | Goddard Glenn | EVP, Chief Financial Officer | M | Restricted Stock Unit | 3062 | $0.00 | 6,126.0000 | 0 | 33.33% | 0.00% |
| Jan. 1, 2023 | Goddard Glenn | EVP, Chief Financial Officer | M | Common Stock | 3062 | $0.00 | 17,831.0000 | 0 | 20.73% | 0.00% |
| Jan. 1, 2023 | Lebwohl David | EVP, Chief Medical Officer | M | Restricted Stock Unit | 3187 | $0.00 | 6,376.0000 | 0 | 33.33% | 0.00% |
| Jan. 1, 2023 | Lebwohl David | EVP, Chief Medical Officer | M | Common Stock | 3187 | $0.00 | 28,261.0000 | 0 | 12.71% | 0.00% |
| Jan. 1, 2023 | LEONARD JOHN M | President and CEO | M | Restricted Stock Unit | 7848 | $0.00 | 15,698.0000 | 0 | 33.33% | 0.00% |